Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
19 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
DName-iT from Leuven, company number BE0506754823, closed financial year 2025 with a result of € -74,453 after tax. For that financial year DName-iT recorded a gross margin of € -71,430 and equity of € 110,253. Compared with financial year 2024, the result moved from € -41,225 to € -74,453. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.
€ 110,253
▼ 40% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -74,453
▼ 81 % more loss than in 2024
Profit after tax over the fiscal year.
€ 11,233
▲ € 9,661 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.2 million.
Debts at end 2025
€ 217,000
Loans from banks and other lenders, long and short.
€ 57,660
▲ € 53,452 vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -57,851 | € -32,827 | € -38,327 | € -71,430 | ▼ € 33,104 |
| Profit after taxes | € -58,623 | € -34,596 | € -41,225 | € -74,453 | ▼ € 33,228 |
| Equity | € 260,526 | € 225,931 | € 184,706 | € 110,253 | ▼ 40% |
| Total debts | € 248,031 | € 278,642 | € 319,875 | € 402,201 | ▲ 26% |
| Cash | € 5,122 | € 1,045 | € 1,572 | € 11,233 | ▲ € 9,661 |
| Retained profit | € -1,039,474 | € -1,074,069 | € -1,115,294 | € -1,189,747 | ▼ € 74,453 |
| Bank debt | € 217,000 | € 217,000 | € 217,000 | € 217,000 | |
| Balance sheet total | € 508,558 | € 504,573 | € 504,581 | € 512,454 | ▲ 2% |
Key figures of DName-iT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DName-iT?
What happened at DName-iT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- EMV Director Services Ltd stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 74,453. filed late Source: NBB ↗
- EMV Director Services Ltd became a director. NBB
- Harelias stepped down as director. NBB
- Harelias became a director. NBB
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 58,623 loss in 2022 to € 74,453 loss in 2025.
Management
Directors
According to the 2025 annual accounts
Director · represented by Harry Cuppens
since 2020 · until 2025
Director · represented by Ilian Petkov Iliev
since 2026 · until 2031
Establishments
Establishment units
Physical locations of this company
Gaston Geenslaan 1
3001 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 19 companies are registered at this address.
All companies at this address →reMYND
€ -217,249 gross margin · 2025
miDiagnostics
€ 24,934 revenue · 2025
Pledge Therapeutics
€ -644,682 gross margin · 2025
PALEO
€ 1.5 million gross margin · 2025
Fishway
€ 413,084 gross margin · 2025
+14 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0506.754.823
- VAT number
- BE 0506.754.823
- Registered office
- Gaston Geenslaan 1, 3001 Leuven
- Names & denominations
- DName-iT
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 11 December 2014
- Peppol
- Active · Active since 2 Jul 2025
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Markt- en opinieonderzoek